Investors with an eye on the burgeoning biotechnology sector may find Rapport Therapeutics, Inc. (NASDAQ: RAPP) a compelling opportunity, especially with a potential upside of 34.23% as suggested by analyst..
Xencor, Inc. (NASDAQ: XNCR) has captured investor attention with its promising pipeline of engineered antibodies targeting cancer and autoimmune diseases. As a clinical-stage biopharmaceutical company, Xencor’s focus on innovative treatments..
Septerna, Inc. (NASDAQ: SEPN) is capturing investor attention with its promising position in the biotechnology sector, focusing on breakthrough therapies for complex and underserved medical conditions. With a market cap..
Organogenesis Holdings Inc. (NASDAQ: ORGO) is catching the eye of investors with a compelling potential upside of 216.21%, according to recent analyst ratings. This regenerative medicine company, with a market..
Emergent BioSolutions Inc. (NASDAQ: EBS), a key player in the healthcare sector, is garnering attention with an enticing potential upside of 31.43%. Investors are eyeing this company as it navigates..
Autolus Therapeutics plc (NASDAQ: AUTL), a UK-based clinical-stage biopharmaceutical company, has captured the attention of investors with its promising pipeline of T cell therapies targeting cancer and autoimmune diseases. Operating..
STAAR Surgical Company (NASDAQ: STAA), a significant player in the Medical Instruments & Supplies industry, has been making waves with its innovative approaches to vision correction. Headquartered in Lake Forest,..
Akebia Therapeutics, Inc. (NASDAQ: AKBA) presents an intriguing opportunity for investors in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a current market cap of..
AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector, stands out for its innovative contributions to medical technology. Headquartered in Latham, New York, AngioDynamics designs and manufactures medical..
Butterfly Network, Inc. (NYSE: BFLY), a prominent player in the healthcare sector, particularly in the medical devices industry, has been capturing the attention of investors with its innovative ultrasound imaging..
Celcuity Inc. (NASDAQ: CELC) stands out in the competitive biotechnology sector with its promising pipeline and strategic partnerships. Despite a recent minor dip of 0.06% in stock price, Celcuity’s market..
AxoGen, Inc. (NASDAQ: AXGN), a key player in the healthcare sector specializing in medical devices for peripheral nerve regeneration, is capturing the attention of investors due to its impressive market..
For investors with a keen eye on the healthcare sector, Humacyte, Inc. (NASDAQ: HUMA) presents an intriguing opportunity. As a biotechnology company specializing in the development of bioengineered human tissues,..
LifeMD, Inc. (LFMD) stands at a pivotal point in the healthcare industry as a direct-to-patient telehealth pioneer, serving the U.S. market with a spectrum of medical services and pharmacy solutions...
AtaiBeckley Inc. (ATAI), a clinical-stage biopharmaceutical company, stands at the forefront of mental health treatment innovation, boasting a market capitalization of $1.47 billion. Focused on developing breakthrough therapies for treatment-resistant..
AMN Healthcare Services Inc (NYSE: AMN), a prominent player in the healthcare sector, is capturing attention with its comprehensive suite of workforce solutions tailored for the medical care facilities industry...
Simulations Plus, Inc. (NASDAQ: SLP) is a key player in the healthcare sector, specifically within the health information services industry. Headquartered in Research Triangle Park, North Carolina, Simulations Plus leverages..
Sonida Senior Living, Inc. (SNDA), a notable player in the healthcare sector, specifically within the medical care facilities industry, is garnering attention for its strategic positioning in the senior housing..
Orthofix Medical Inc. (NASDAQ: OFIX), a key player in the healthcare sector specializing in medical devices, presents an intriguing prospect for investors with its substantial potential upside. The company, which..
Cullinan Therapeutics, Inc. (CGEM), a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, is capturing the attention of the investment community with its promising pipeline and substantial upside potential. Operating in..
